Effect of cilostazol on arterial stiffness and vascular adhesion molecules in type 2 diabetic patients with metabolic syndrome: a randomised, double-blind, placebo-controlled, crossover trial

BACKGROUND: The phosphodiesterase inhibitor cilostazol has beneficial effects on atherosclerosis by virtue of vasodilatory and antiplatelet effects. However, less is known about the effect of cilostazol on arterial stiffness and biochemical markers related to vascular inflammation and endothelial dy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Nam Hoon, Kim, Hee Young, An, Hyonggin, Seo, Ji A, Kim, Nan Hee, Choi, Kyung Mook, Baik, Sei Hyun, Choi, Dong Seop, Kim, Sin Gon
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3733748/
https://ncbi.nlm.nih.gov/pubmed/23886346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-5-41
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados